HAE
HAEMONETICS CORP
NYSE · Healthcare · Medical - Instruments & Supplies · US
$108.42
+0.76%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$107.50
From 52W high−0.35%
Volume1.29M
Market cap$4.93B
P/E (TTM)52.6x
P/S (TTM)3.6x
Div yield—
Key dataSep 18, 2026
Open
$107.50
From 52W high
−0.35%
Volume
1.29M
Market cap
$4.93B
ValuationView details →
P/E (Fwd)
19.8x
EV/EBITDA
22.5x
P/E (TTM)
52.6x
RSI (14)
73.4
MomentumView details →
1D Return
+0.76%
YTD Return
+36.53%
SummaryUpdated Jun 1, 2026
Haemonetics Corporation (NASDAQ:HAE) is a Boston-based healthcare company founded in 1971 that specializes in blood and plasma management technologies. The company has evolved from its origins in blood collection to become a leading provider of automated medical devices, software systems, and disposable products that help healthcare providers and plasma collection centers manage blood components more efficiently. Haemonetics went public in 1991 and has since grown through both organic expansion and strategic acquisitions to serve three primary markets: plasma collection, blood centers, and hospitals worldwide.
Similar companies
Latest newsMore news →
Haemonetics Corporation acquired Vivasure Medical Limited, with Orchestra BioMed receiving a $6.1 million milestone payment on September 14, 2026 as part of the deal.5d agoHaemonetics Corp shares surged 15.9% to $104.65 on August 18, 2026.33d agoHaemonetics Corporation announced that its financial results for the first quarter of fiscal year 2027, which ended June 27, 2026, are available on its Investor Relations website.45d ago